BBPvsPTHETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. BBP's top 1 sector exposures are Healthcare. In contrast, PTH's top sector exposures are Healthcare and Consumer Non-Cyclicals. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.72% for PTH. BBP is up 28.1% year-to-date (YTD) with +$66M in YTD flows. PTH performs worse with 17.67% YTD performance, and +$145M in YTD flows. Run a side-by-side ETF comparison of BBP and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs PTH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 10/23/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP PTH | -2.17%-3.42% | +5.26%-1.48% | +28.10%+17.67% | +41.42%+28.89% | +121.19%+104.86% | +99.68%+12.93% |
| Flows | BBP PTH | +$5M+$9M | +$26M+$57M | +$66M+$145M | +$78M+$155M | +$83M+$98M | +$76M-$114M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP PTH | +28.19%+28.93% | +26.47%+26.81% | +25.00%+26.12% | +26.86%+25.90% |
| Max drawdown | BBP PTH | -8.70%-12.72% | -9.59%-12.72% | -25.54%-27.71% | -37.61%-47.24% |
| Max drawdown duration | BBP PTH | 65d65d | 48d65d | 292d353d | 586d1688d |
Trading data
BBP | PTH | |
Last sale 10/26/2026 at 1:30 PM | $102.33 | $58.96 |
| Previous close 10/23/2026 | $102.07 | $58.52 |
| Consolidated volume 10/23/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of September 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | PTH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 10/26/2026 at 1:30 PM
Live
Closed
BBP | PTH | |
|---|---|---|
| Last price | $102.33 | $58.96 |
| 1D performance | +0.26% | +0.75% |
| AuM | $127.72 M | $285.48 M |
| E/R | 0.34% | 0.72% |
Characteristics
BBP | PTH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Invesco |
| Benchmark | LifeSci Biotechnology Products Index | Dorsey Wright Healthcare Technical Leaders Index |
| N° of holdings | 66 | 54 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | October 12, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
85.98%
Other
14.02%
PTH
USA
90%
Other
10%
Sectors
BBP
Healthcare
98.44%
Other
1.56%
PTH
Healthcare
99.31%
Other
0.69%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
31.08%
PTH
Total weight of top 15 holdings out of 15
49.11%
Top 15 holdings
Data as of August 31, 2026
BBP
Moderna, Inc.
3.58%
Crinetics Pharmaceuticals, Inc.
2.94%
Omeros Corp.
2.49%
Iovance Biotherapeutics, Inc.
2.36%
Verastem, Inc.
2.15%
Precigen, Inc.
1.99%
Halozyme Therapeutics, Inc.
1.84%
Zai Lab Ltd.
1.82%
Kiniksa Pharmaceuticals International Plc
1.81%
Kura Oncology, Inc.
1.72%
BeOne Medicines Ltd.
1.70%
Rigel Pharmaceuticals, Inc.
1.69%
Nuvation Bio, Inc.
1.69%
ACADIA Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
PTH
Revolution Medicines, Inc.
5.32%
Roivant Sciences Ltd.
5.01%
Guardant Health, Inc.
4.73%
Moderna, Inc.
4.51%
BrightSpring Health Services, Inc.
3.76%
Axsome Therapeutics, Inc.
3.57%
Erasca, Inc.
2.89%
10X Genomics, Inc.
2.85%
Oruka Therapeutics, Inc.
2.50%
Replimune Group, Inc.
2.46%
Twist Bioscience Corp.
2.43%
Travere Therapeutics, Inc.
2.38%
Axogen, Inc.
2.31%
Liquidia Corp.
2.29%
Relay Therapeutics, Inc.
2.12%
Frequently asked questions about BBP and PTH
How have the BBP and PTH ETFs performed in 2026?
As of October 23, 2026, BBP is up 28.1% year-to-date (YTD), while PTH has returned 17.67%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or PTH?
Year-to-date, the BBP ETF saw +$66M in flows, compared to +$145M for PTH.
Which ETF is more volatile: BBP or PTH?
Over the past year, BBP had a volatility of 26.47%, while PTH experienced 26.81%.
Which ETF is bigger: BBP or PTH?
As of October 23, 2026, BBP holds $127.72 M in assets under management (AUM), while PTH manages $285.48 M.
What sectors do the BBP and PTH ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, PTH focuses on Healthcare.
What are the top holdings of the BBP ETF and PTH ETF?
BBP top holdings include Moderna, Inc., Crinetics Pharmaceuticals, Inc. and Omeros Corp.. PTH holds in its top three: Revolution Medicines, Inc., Roivant Sciences Ltd. and Guardant Health, Inc..
Which ETF is more diversified: BBP or PTH?
BBP holds 66 securities with 31.08% of its assets in the top 15. PTH has 54 securities and a top 15 weight of 49.11%.
Advertisement
Latest news about BBP & PTH
Advertisement
